Business
Press Release Mar 19 2023
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated March 18, 2023, titled "Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata".
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":" Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated March 18, 2023, titled \"Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata\". View Attachment","length":422,"tagName":"div"}]